跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DESVENLAFAXINA ALTER 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DESVENLAFAXINA ALTER 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
DESVENLAFAXINA ALTER 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Laboratorios Alter S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 21, 2022
Approval ID
53e452ece1eb199f
Company
Laboratorios Alter S.A.
Type
Standard
Approval Details
Approval Id
53e452ece1eb199f
Drug Cima Aemps Name
DESVENLAFAXINA ALTER 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
86688
Holder Company Name
Laboratorios Alter S.A.
Marketing Company Name
Laboratorios Alter S.A.
Authorization Date
2022-03-21
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Alter S.A.
Active Ingredients
DESVENLAFAXINA BENZOATO
73,16 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 21, 2022
Approval ID
53e452ece1eb199f
Type
Standard
Back to CIMA-AEMPS Approvals